A Final Report on the Real Impact of the COVID-19 Pandemic on the Diagnosis of Gastrointestinal Cancer in Akita Prefecture, Japan in 2022

The Tohoku Journal of Experimental Medicine, Journal Year: 2024, Volume and Issue: 263(2), P. 161 - 168

Published: Jan. 1, 2024

The long-term impact of the coronavirus disease 2019 (COVID-19) pandemic on disruption gastrointestinal cancer diagnoses remains unclear. This study investigated actual esophagogastric (EGC) and colorectal (CRC) up to third year in Akita Prefecture, Japan, using population-based registry data. We collected data annual number EGC CRC a database from collaborative Prefecture hospital-based registration. net cancers diagnosed first three years (2020-2022) were compared with those before (2017-2019). Changes proportion stage initial treatment for after then compared. total EGCs was 9.3% lower than before, probably due its declining trend. CRCs exceeded that suggesting successful recovery diagnostic procedure. stages remained largely unchanged onset pandemic. Based pandemic, caused by is settling down without any substantial progression, even area highest incidence all Japan.

Language: Английский

Association between COVID-19 Diagnosis and In-Hospital Mortality of Hospitalized patients with ST-Segment Elevation Myocardial Infarction

The Egyptian Journal of Hospital Medicine, Journal Year: 2024, Volume and Issue: 95(1), P. 1868 - 1875

Published: April 1, 2024

Introduction:The 2019 coronavirus disease pandemic (Covid-19) is the worst global health crisis right now.The clinical course of covid-19 often accompanied by hypercoagulation state, which means that COVID-19 patients could develop a number cardiac conditions, such as myocarditis, stress-induced cardiomyopathy, etc.The possibility morbidity well mortality increased among individuals with who have ST-elevation myocardial infarction (STEMI) in comparison without virus are same gender and age.Subjects methods: We collected data from records form personal history, comorbidities laboratory studies including: complete blood picture (CBC), coagulation profile, D-Dimer, serum biochemical tests including biomarkers ferritin, rapid test or PCR, computed tomography (CT), ECG results echocardiography if found.We intended to find association STEMI outcomes on patient presented Emergency Department at Suez Canal University.Results: In-hospital rates were 34.04% for along compared 4.3% those COVID-19.COVID 19 had leukocytosis lymphocytopeni.Moreover, COVID elevated d-dimer, TLC CRP.Conclusion: When not diagnosed COVID-19, significantly greater in-hospital when they also concurrent out-of-hospital infection.

Language: Английский

An approach to COVID‑19 and oncology: From impact, staging and management to vaccine outcomes in cancer patients: A systematic review and meta‑analysis

Experimental and Therapeutic Medicine, Journal Year: 2024, Volume and Issue: 29(2)

Published: Dec. 23, 2024

The COVID‑19 pandemic has had a global impact, with >771 million confirmed cases and 6 deaths reported by October 2023. Cancer patients, due to their immunosuppressed status, face an increased infection risk higher complications. present study aimed assess clinical outcomes in COVID‑19‑infected cancer focusing on mortality rates other aspects, providing valuable insight for better protection outcomes. This systematic review was conducted searching the PubMed, Cochrane Embase databases from August 2023 following PRISMA guidelines. Studies 2020 pertaining impact of patients previously diagnosed malignancies were considered. Inclusion criteria entailed pre‑existing malignancy diagnosis, any aspect patient's management. written English exclusively reviewed. Post‑COVID‑19 diagnoses, case reports, articles data‑insufficient studies excluded. Screening consensus eligibility carried out team four authors, disputes resolved non‑screening author. Data extraction performed five‑author team, detailing population characteristics, as well patient related COVID‑19. Cross‑checking same conflicts third 27 explored COVID‑19's oncology, revealing diverse sample sizes (1,807,559 177 participants). spanned various types, including gastric adenocarcinoma, breast, lung, gynecologic, colorectal non‑melanoma skin cancer. Mortality among compared those without. Gastric adenocarcinoma exhibited 5.9% rate. Thoracic faced elevated gastrectomies decreased. A meta‑analysis (10 studies, 5,151 patients) showed 19.1% rate contrasting 1% non‑COVID‑19 (5 54,528 patients). odds ratio vs. 0.1036 (3 3,496 consistently during pandemic, specific cancers showing unique impacts. significant Patients thoracic risks, influencing surgical trends. Meta‑analysis revealed overall counterparts.

Language: Английский